$VICR

Schmidt James F sold $766K of VICR

Schmidt James F (CFO, Treasurer, Secretary) sold 2,124 shares of VICOR CORP (VICR) at an average of $360.60 ($351.38–$367.06, $0.77M total) across 10 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schmidt James F
Published Jun 23, 2026, 6:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 6:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure updates the insider activity record and can marginally influence sentiment, but it does not include any new company fundamentals (earnings, guidance, contracts, litigation, or product updates).

02

Market read

A fresh Form 4 provides a concrete datapoint on insider selling size and timing, but the pre-arranged nature limits fundamental interpretation.

03

What to watch

Traders may want to compare with prior insider activity cadence and whether other executives also sold around the same window; the article provides only this single Form 4.

Relevance 4/10Novelty 6/10Timing: today’s SEC Form 4 filing (filed 2026-06-23)

Background

The article is an SEC Form 4 insider transaction: James F Schmidt (CFO/Treasurer/Secretary) sold VICR shares across 10 trades on 2026-06-22 under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

ViCOR Corp CFO/Treasurer/Secretary James F Schmidt sold $765,905 of VICR shares via a Rule 10b5-1 plan, leaving 0 shares after the trades.

Expected impact

Likely limited near-term impact; any effect should fade unless followed by additional disclosures or fundamental news.

Evidence & confidence

The filing is a scheduled open-market sale with pre-arranged 10b5-1 terms and no accompanying operational or guidance change in the text.

Market effects

No sector read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification/tax planning rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale; shares sold total $765,905.42 and holdings after transaction were 0 shares.

  • Schmidt James F

    CFO, Treasurer, Secretary; executed open-market sales under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: